What is OS Therapies's interest expense, nonoperating?

OS Therapies (OSTX) reported interest expense, nonoperating of $75.34K in Q1 2026.

What does interest expense, nonoperating mean?

Represents the cost of servicing debt obligations that are not directly related to core operations. High levels of this expense can indicate significant leverage and potential liquidity risks for the company.

OS Therapies OSTX Interest Expense, Nonoperating

Interest Expense, Nonoperating at other companies

CTO

Citius Oncology, Inc.CTOR

$33.03K—

Other financials

Income statement

See full

Operating income-$10.2M-103%

Net income-$10.4M-168%

EPS (diluted)-$0.27-50.0%

Balance sheet

See full

Cash & equivalents$917.6K-69.1%

Total debt$20.0M—

Total equity-$10.8M-159%

Total assets$7.3M+71.7%

Cash flow

See full

Operating cash flow-$4.6M-32.6%

CapEx$316.4K—

Free cash flow-$3.7M—

Valuation

See full

Market cap$84.62M+65.5%

Enterprise value$103.7M—

Returns & leverage

See full

Return on equity470%—

Debt / equity-1.8×—

Current ratio0.1×-1.1×

Where this comes from

Reported directly by OS Therapies in its filing.

Tagged under the XBRL concept us-gaap:InterestExpenseNonoperating.

The official record: OS Therapies’s 10-Q, filed May 18, 2026, on SEC EDGAR. View the filing →

Ask your AI about OS Therapies's interest expense, nonoperating.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is OS Therapies's interest expense, nonoperating?: OS Therapies (OSTX) reported interest expense, nonoperating of $75.34K in Q1 2026.
What does interest expense, nonoperating mean?: Represents the cost of servicing debt obligations that are not directly related to core operations. High levels of this expense can indicate significant leverage and potential liquidity risks for the company.